Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-05-06

Clinical Trial Update: XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating XELOX with capecitabine maintenance versus XELOX in elderly patients with metastatic gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Harbin Medical University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN